Your browser doesn't support javascript.
loading
Prevention of exercise-induced hypoglycemia in 12 patients with type 1 diabetes running the Paris Marathon using continuous glucose monitoring: A prospective, single-center observational study.
Thuillier, Philippe; Domun, Nikhil; Sonnet, Emmanuel; Le Ven, Florent; Roudaut, Caroline; Kergus, Anne; Kerlan, Véronique; Roudaut, Nathalie.
Afiliación
  • Thuillier P; Department of Endocrinology, University Hospital of Brest, France; EA GETBO 3878, University Hospital of Brest, France. Electronic address: philippe.thuillier@chu-brest.fr.
  • Domun N; Department of Endocrinology, University Hospital of Brest, France; EA GETBO 3878, University Hospital of Brest, France.
  • Sonnet E; Department of Endocrinology, University Hospital of Brest, France; EA GETBO 3878, University Hospital of Brest, France.
  • Le Ven F; EA GETBO 3878, University Hospital of Brest, France; Department of Cardiology, University Hospital of Brest, France.
  • Roudaut C; Department of Endocrinology, University Hospital of Brest, France.
  • Kergus A; Department of Endocrinology, University Hospital of Brest, France.
  • Kerlan V; Department of Endocrinology, University Hospital of Brest, France; EA GETBO 3878, University Hospital of Brest, France.
  • Roudaut N; Department of Endocrinology, University Hospital of Brest, France; EA GETBO 3878, University Hospital of Brest, France.
Diabetes Metab ; 48(2): 101321, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35032674
ABSTRACT

OBJECTIVE:

To investigate the glycemic balance before, during and after the 2016 Paris Marathon using a real-time continuous glucose monitoring (RT-CGM) system in patients with type 1 diabetes mellitus in a prospective single-center observational study.

METHODS:

Inclusion criteria were as follows type 1 diabetes mellitus; age ≥18 years; HbA1c < 9%. Participants performed two 2h-preparatory races (PR) before the Marathon and were monitored with RT-CGM 24h before, during and 72h after each race. Hypoglycemic events were prevented via carbohydrate intake / insulin dose adjustments. The primary outcome was area under the curve (AUC) < 70 and > 200 mg/dl and percentage of time spent in euglycemia, hypoglycemia, and hyperglycemia during the races.

RESULTS:

Twelve patients (2F/10M; median HbA1c=6.8%) were included and completed the study. Median AUC < 70 and time spent in hypoglycemia (< 70 mg/dl) during the PRs and Marathon were equal to 0. However, no hypoglycemic episodes occurred during Marathon, while two patients experienced hypoglycemia during PR1 and PR2. There was a significant increase in AUC > 200 mg/dl during races between PR2 and Marathon (P = 0.009) although the median time spent > 200mg/dl was not statistically different in Marathon versus PR2 (48.4% versus 18.4%; P = 0.09). Median time spent in euglycemia (70-200 mg/dl) was lower in Marathon versus PR2 (51.6 versus 58%; P = 0.03).

CONCLUSION:

Our study proposes a medical support protocol for extreme endurance physical activity in patients with type 1 diabetes mellitus. Our results suggest that RT-CGM, coupled with adjustments in carbohydrate intake and insulin doses, appears to be effective to prevent hypoglycemia during and after exercise.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Diabetes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Diabetes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article